Showing results (1-10 of 36) with videos related to
Sort By:
Pageof 4
Current Aging Science|November 12, 2016
Role of Ageing and Oxidative Stress in Regulation of Amyloid-Degrading Enzymes and Development of NeurodegenerationNatalia N Nalivaeva, Anthony J TurnerPeptides|February 13, 2022
Angiotensin-converting enzyme 2 (ACE2): Two decades of revelations and re-evaluationAnthony J Turner, Natalia N NalivaevaFEBS Letters|May 21, 2013
The amyloid precursor protein: a biochemical enigma in brain development, function and diseaseNatalia N Nalivaeva, Anthony J TurnerChemico-Biological Interactions|April 12, 2016
AChE and the amyloid precursor protein (APP) - Cross-talk in Alzheimer's diseaseNatalia N Nalivaeva, Anthony J TurnerBritish Journal of Pharmacology|February 3, 2019
Targeting amyloid clearance in Alzheimer's disease as a therapeutic strategyNatalia N Nalivaeva, Anthony J TurnerAnnals of the New York Academy of Sciences|February 1, 2005
Targeting amyloid-degrading enzymes as therapeutic strategies in neurodegenerationAnthony J Turner, Lilia Fisk, Natalia N NalivaevaJournal of Molecular Neuroscience : MN|March 28, 2022
Caspase Inhibition Restores NEP Expression and Rescues Olfactory Deficit in Rats Caused by Prenatal HypoxiaDimitrii Vasilev, Nadezhda M Dubrovskaya, Natalia N NalivaevaExperimental Biology and Medicine (Maywood, N.J.)|June 3, 2006
Regulation of endothelin-converting enzyme-1 expression in human neuroblastoma cellsLilia Fisk, Natalia N Nalivaeva, Anthony J TurnerTrends in Pharmacological Sciences|September 19, 2009
Sodium valproate: an old drug with new rolesNatalia N Nalivaeva, Nikolai D Belyaev, Anthony J TurnerFrontiers in Physiology|June 28, 2012
Lipid rafts and Alzheimer's disease: protein-lipid interactions and perturbation of signalingDavid A Hicks, Natalia N Nalivaeva, Anthony J TurnerPageof 4